MX355725B - Ratones con complejo principal de histocompatibilidad modificado geneticamente. - Google Patents

Ratones con complejo principal de histocompatibilidad modificado geneticamente.

Info

Publication number
MX355725B
MX355725B MX2014004895A MX2014004895A MX355725B MX 355725 B MX355725 B MX 355725B MX 2014004895 A MX2014004895 A MX 2014004895A MX 2014004895 A MX2014004895 A MX 2014004895A MX 355725 B MX355725 B MX 355725B
Authority
MX
Mexico
Prior art keywords
genetically modified
human
major histocompatibility
histocompatibility complex
modified major
Prior art date
Application number
MX2014004895A
Other languages
English (en)
Other versions
MX2014004895A (es
Inventor
J Murphy Andrew
Stevens Sean
Macdonald Lynn
Mcwhirter John
Voronina Vera
Gurer Cagan
Harris Faith
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of MX2014004895A publication Critical patent/MX2014004895A/es
Publication of MX355725B publication Critical patent/MX355725B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a animales no humanos modificados genéticamente que expresan polipéptido de CPH I humano/no humano quimérico y/o polipéptidos de microglobulina beta2 humano o humanizado, así como embriones no humanos, células y tejidos que comprenden a los mismos. También se proporcionan construcciones para producir animales modificados genéticamente y métodos para la elaboración de los mismos. Se proporcionan métodos de uso de animales modificados genéticamente para estudiar diversos aspectos del sistema inmunitario humano.
MX2014004895A 2011-10-28 2012-10-26 Ratones con complejo principal de histocompatibilidad modificado geneticamente. MX355725B (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161552582P 2011-10-28 2011-10-28
US201161552587P 2011-10-28 2011-10-28
US201261700908P 2012-09-14 2012-09-14
PCT/US2012/062042 WO2013063346A1 (en) 2011-10-28 2012-10-26 Genetically modified major histocompatibility complex mice

Publications (2)

Publication Number Publication Date
MX2014004895A MX2014004895A (es) 2014-09-12
MX355725B true MX355725B (es) 2018-04-27

Family

ID=47178940

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2020010763A MX2020010763A (es) 2011-10-28 2012-10-26 Ratones con complejo principal de histocompatibilidad modificado geneticamente.
MX2014004895A MX355725B (es) 2011-10-28 2012-10-26 Ratones con complejo principal de histocompatibilidad modificado geneticamente.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2020010763A MX2020010763A (es) 2011-10-28 2012-10-26 Ratones con complejo principal de histocompatibilidad modificado geneticamente.

Country Status (25)

Country Link
US (3) US9615550B2 (es)
EP (4) EP4311833A3 (es)
JP (4) JP6154391B2 (es)
KR (3) KR102295746B1 (es)
CN (3) CN104039132B9 (es)
AU (3) AU2012324016C1 (es)
BR (1) BR112014009259A2 (es)
CA (2) CA3074400A1 (es)
CY (2) CY1119657T1 (es)
DK (2) DK3262932T3 (es)
ES (3) ES2962287T3 (es)
HK (2) HK1200272A1 (es)
HR (2) HRP20171761T1 (es)
HU (2) HUE045879T2 (es)
IL (3) IL232097A (es)
LT (2) LT3262932T (es)
MX (2) MX2020010763A (es)
MY (2) MY164836A (es)
NZ (1) NZ734532A (es)
PL (2) PL2770821T3 (es)
PT (2) PT3262932T (es)
RS (2) RS59082B1 (es)
SG (2) SG11201400933VA (es)
SI (2) SI3262932T1 (es)
WO (1) WO2013063346A1 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9591835B2 (en) 2011-10-28 2017-03-14 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex animals
ES2525368T3 (es) 2011-10-28 2014-12-23 Regeneron Pharmaceuticals, Inc. IL-6 y receptor de IL-6 humanizados
SI2958938T1 (sl) 2013-02-20 2019-08-30 Regeneron Pharmaceuticals, Inc. Miši, ki izražajo humanizirane koreceptorje za celice T
US20150342163A1 (en) 2013-02-22 2015-12-03 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex mice
CN110192541B (zh) * 2013-02-22 2022-02-18 瑞泽恩制药公司 表达人源化主要组织相容性复合物的小鼠
JP6456351B2 (ja) * 2013-03-11 2019-01-23 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． キメラ主要組織適合複合体（ｍｈｃ）クラスｉ分子を発現する遺伝子導入マウス
HUE063376T2 (hu) 2013-09-23 2024-01-28 Regeneron Pharma Humanizált szignál-szabályozó fehérje gént tartalmazó nem humán állatok
SG11201601828XA (en) 2013-10-15 2016-04-28 Regeneron Pharma Humanized il-15 animals
WO2015056774A1 (ja) * 2013-10-18 2015-04-23 大鵬薬品工業株式会社 Ｈｌａクラスｉ発現非ヒト動物
SG11201603360QA (en) 2013-11-19 2016-05-30 Regeneron Pharma Non-human animals having a humanized b-cell activating factor gene
CA2935472C (en) 2014-04-08 2024-02-20 Regeneron Pharmaceuticals, Inc. Non-human animals having humanized fc-gamma receptors
MA51519A (fr) 2014-05-05 2020-11-11 Regeneron Pharma Animaux c5 et c3 humanisés
NO2785538T3 (es) 2014-05-07 2018-08-04
PT3157956T (pt) 2014-06-19 2020-04-09 Regeneron Pharma Animais não humanos com um gene 1 de morte programada humanizada em células
AU2015317370A1 (en) 2014-09-19 2017-03-23 Regeneron Pharmaceuticals, Inc. Chimeric antigen receptors
DK3223605T3 (da) 2014-11-24 2020-11-16 Regeneron Pharma Ikke-humane dyr, der eksprimerer humaniseret cd3-kompleks
PL3086637T3 (pl) 2014-12-05 2019-09-30 Regeneron Pharmaceuticals, Inc. Zwierzęta nie będące człowiekiem mające humanizowany gen kompleksu różnicowania 47
US9913461B2 (en) 2014-12-09 2018-03-13 Regeneron Pharmaceuticals, Inc. Genetically modified mouse whose genome comprises a humanized CD274 gene
CA2969847A1 (en) 2014-12-10 2016-06-16 Regents Of The University Of Minnesota Genetically modified cells, tissues, and organs for treating disease
DK3280257T3 (da) 2015-04-06 2023-09-04 Regeneron Pharma Humaniseret T-celle-formidlet immunrespons i ikke-humane dyr
RU2730599C2 (ru) * 2015-04-13 2020-08-24 Ридженерон Фармасьютикалз, Инк. Гуманизированные мыши с нокином sirpa-il15 и способы их использования
WO2017087780A1 (en) 2015-11-20 2017-05-26 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized lymphocyte-activation gene 3
ES2886958T3 (es) 2016-02-29 2021-12-21 Regeneron Pharma Roedores que tienen un gen TMPRSS humanizado
CA3026088A1 (en) 2016-06-03 2017-12-07 Regeneron Pharmaceuticals, Inc. Non-human animals expressing exogenous terminal deoxynucleotidyltransferase
CN109456942A (zh) * 2017-09-06 2019-03-12 亘喜生物科技（上海）有限公司 通用型嵌合抗原受体t细胞制备技术
EP3585162B1 (en) 2017-09-29 2023-08-30 Regeneron Pharmaceuticals, Inc. Rodents comprising a humanized ttr locus and methods of use
EP3687287B1 (en) 2017-09-29 2023-07-12 Regeneron Pharmaceuticals, Inc. Rodents expressing humanized c1q complex
IL310006A (en) 2017-11-30 2024-03-01 Regeneron Pharma Non-human animals containing a humanized TRKB locus
WO2019190922A1 (en) 2018-03-24 2019-10-03 Regeneron Pharmaceuticals, Inc. Genetically modified non-human animals for generating therapeutic antibodies against peptide-mhc complexes, methods of making and uses thereof
WO2019190990A1 (en) 2018-03-26 2019-10-03 Regeneron Pharmaceuticals, Inc. Humanized rodents for testing therapeutic agents
LT3823443T (lt) 2018-07-16 2024-08-12 Regeneron Pharmaceuticals, Inc. Ditra ligos graužikų modeliai ir jų naudojimas
EP3772929B1 (en) 2019-04-04 2023-11-15 Regeneron Pharmaceuticals, Inc. Rodents comprising a humanized coagulation factor 12 locus
WO2020247452A1 (en) 2019-06-04 2020-12-10 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized ttr locus with a beta-slip mutation and methods of use
WO2020247812A1 (en) 2019-06-07 2020-12-10 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized albumin locus
WO2021139799A1 (en) * 2020-01-10 2021-07-15 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric mhc protein complex
WO2022132943A1 (en) 2020-12-16 2022-06-23 Regeneron Pharmaceuticals, Inc. Mice expressing humanized fc alpha receptors
WO2022133155A1 (en) * 2020-12-16 2022-06-23 Xenotherapeutics, Inc. Humanization of beta2-microglobulin in porcine genome resulting in functional expression of human βeta2-microglobulin within donor cells, tissues, or organs
IL307238A (en) 2021-03-31 2023-11-01 Regeneron Pharma Transgenic mice containing human components of the cellular immune system with an enhanced diversity of the TCRB repertoire
WO2023240124A1 (en) 2022-06-07 2023-12-14 Regeneron Pharmaceuticals, Inc. Pseudotyped viral particles for targeting tcr-expressing cells
WO2023240109A1 (en) 2022-06-07 2023-12-14 Regeneron Pharmaceuticals, Inc. Multispecific molecules for modulating t-cell activity, and uses thereof
WO2024064860A1 (en) 2022-09-22 2024-03-28 Regeneron Pharmaceuticals, Inc. Genetically modified mice expressing components of human cellular immune system
WO2024159071A1 (en) 2023-01-27 2024-08-02 Regeneron Pharmaceuticals, Inc. Modified rhabdovirus glycoproteins and uses thereof

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0437576B1 (en) 1989-07-25 2002-07-03 Cell Genesys, Inc. Homologous recombination for universal donor cells and chimeric mammalian hosts
US5413923A (en) 1989-07-25 1995-05-09 Cell Genesys, Inc. Homologous recombination for universal donor cells and chimeric mammalian hosts
US5574205A (en) 1989-07-25 1996-11-12 Cell Genesys Homologous recombination for universal donor cells and chimeric mammalian hosts
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
GB9100481D0 (en) 1991-01-10 1991-02-20 Inst Nat Sante Rech Med Genetically engineered mice
WO1993005817A1 (en) 1991-09-19 1993-04-01 President And Fellows Of Harvard College Transgenic mhc class i and class ii antigen-deficient mammals
EP0663952A4 (en) 1992-09-11 1997-06-11 Univ California TRANSGENIC NON-HUMAN ANIMALS WITH TARGETED INTERRUPTED TRANSDUCTION GENES IN LYMPHOCYTES.
US5523226A (en) 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
GB9315303D0 (en) 1993-07-23 1993-09-08 Zeneca Ltd Polypeptide
US5965787A (en) 1995-08-31 1999-10-12 Mayo Foundation For Medical Education And Research HLA-DRBI peptides with specific binding affinity for HLA-DQ molecules: prevention and treatment of rheumatoid arthritis
US6002066A (en) 1996-01-16 1999-12-14 Ortho Pharmaceutical Corp. H2-M modified transgenic mice
EP0910409A4 (en) 1996-03-05 2003-03-19 Scripps Research Inst RECOMBINANT ELEMENTS ENCODING FOR T-LYMPHOCYTE RECEPTORS SPECIFIC TO HLA HUMAN BOUNDARY TUMOR ANTIGENS
CA2722378C (en) 1996-12-03 2015-02-03 Amgen Fremont Inc. Human antibodies that bind tnf.alpha.
CA2302779C (en) 1997-09-16 2010-02-02 Oregon Health Sciences University Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
US6372955B1 (en) 1998-02-17 2002-04-16 Ortho Mcneil Pharmaceutical, Inc. Methods for Producing B cells and antibodies from H2-O modified transgenic mice
WO2001027291A1 (en) * 1999-10-12 2001-04-19 Institut Pasteur Design of a polyepitopic construct for the induction of hla-a2.1 restricted hiv 1 specific ctl responses using hhd mice
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7105348B2 (en) 2000-10-31 2006-09-12 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
JPWO2002047474A1 (ja) 2000-12-13 2004-04-15 住友製薬株式会社 Ｈｌａ−ａ２４発現トランスジェニック動物及びその利用
EP1409646B1 (en) 2000-12-19 2012-06-13 Altor BioScience Corporation Transgenic animals comprising a humanized immune system
FR2827302B1 (fr) * 2001-07-13 2003-10-10 Genoway Cellule et animal transgenique modelisant la presentation antigenique humaine et leurs utilisations
US8895020B2 (en) 2002-04-19 2014-11-25 Washington University Single chain trimers and uses therefor
US7179645B2 (en) * 2002-09-24 2007-02-20 Antigen Express, Inc. Ii-Key/antigenic epitope hybrid peptide vaccines
US7663017B2 (en) * 2003-07-30 2010-02-16 Institut Pasteur Transgenic mice having a human major histocompatability complex (MHC) phenotype, experimental uses and applications
WO2005085438A1 (ja) 2004-03-09 2005-09-15 Nagoya Industrial Science Research Institute ヒト関節リウマチの病態を再現するトランスジェニック非ヒト哺乳動物
CA2827654C (en) 2004-10-19 2019-04-02 Regeneron Pharmaceuticals, Inc. Method for generating an animal homozygous for a genetic modification
JP4830139B2 (ja) * 2006-03-10 2011-12-07 学校法人明治大学 クローン胚の作製方法
NZ547859A (en) * 2006-06-09 2009-05-31 Dec Int Nz Ltd Treatment method and composition for mastitis
EP1878342A1 (en) * 2006-07-13 2008-01-16 Institut Pasteur Immunodeficient mice transgenic for HLA class I and HLA class II molecules and their uses
EP1878798A1 (en) 2006-07-13 2008-01-16 Institut Pasteur Method of producing a multichimeric mouse and applications to study the immunopathogenesis of human tissue-specific pathologies
CN101986783A (zh) * 2007-04-23 2011-03-16 先灵公司 抗mdl-1抗体
ES2665068T3 (es) 2008-03-07 2018-04-24 Regeneron Pharmaceuticals, Inc. Ratones derivados de células ES a partir de inyección de un embrión hospedador diploide
US20090328240A1 (en) 2008-06-24 2009-12-31 Sing George L Genetically modified mice as predictors of immune response
EP2153845A1 (en) * 2008-08-13 2010-02-17 Julius-Maximilians-Universität Würzburg Endoglin peptides, vaccines and methods for preparing the same
DK2517556T4 (da) 2009-07-08 2023-05-15 Kymab Ltd Fremgangsmåde til punkt-specifik rekombination, gnavere og gnaverceller i stand til at udtrykke kimære antistoffer eller kæder
WO2012039779A1 (en) 2010-09-24 2012-03-29 The United States Of America As Represented By The Secretary Of The Navy Humanized transgenic mouse model
SI2958938T1 (sl) 2013-02-20 2019-08-30 Regeneron Pharmaceuticals, Inc. Miši, ki izražajo humanizirane koreceptorje za celice T
CN110192541B (zh) 2013-02-22 2022-02-18 瑞泽恩制药公司 表达人源化主要组织相容性复合物的小鼠
US20150342163A1 (en) 2013-02-22 2015-12-03 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex mice
BR112015030211A2 (pt) * 2013-06-03 2017-08-22 Theravectys Vetores lentivirais contendo uma sequência promotora a montante da mhc de classe i, mhc de classe ii ou microglobulina beta-2
WO2015056774A1 (ja) * 2013-10-18 2015-04-23 大鵬薬品工業株式会社 Ｈｌａクラスｉ発現非ヒト動物
DK3280257T3 (da) 2015-04-06 2023-09-04 Regeneron Pharma Humaniseret T-celle-formidlet immunrespons i ikke-humane dyr

Also Published As

Publication number Publication date
HRP20171761T1 (hr) 2017-12-29
ES2962287T3 (es) 2024-03-18
IL261239A (en) 2018-10-31
AU2012324016B2 (en) 2016-01-28
CN113564188A (zh) 2021-10-29
KR102295746B1 (ko) 2021-09-01
AU2017279797A1 (en) 2018-01-25
AU2012324016A1 (en) 2013-05-16
US20130111617A1 (en) 2013-05-02
EP3563680A1 (en) 2019-11-06
EP3262932A1 (en) 2018-01-03
AU2017279797C1 (en) 2021-07-15
NZ734532A (en) 2022-12-23
ES2741649T3 (es) 2020-02-11
JP2014532412A (ja) 2014-12-08
HRP20191420T1 (hr) 2019-11-15
MY178723A (en) 2020-10-20
US9615550B2 (en) 2017-04-11
AU2017279797B2 (en) 2020-10-22
SI2770821T1 (en) 2018-01-31
IL261239B (en) 2019-11-28
EP2770821B1 (en) 2017-09-13
AU2016202688A1 (en) 2016-05-19
BR112014009259A2 (pt) 2020-10-27
WO2013063346A1 (en) 2013-05-02
HK1249712B (zh) 2020-06-26
US20170164590A1 (en) 2017-06-15
JP2017143840A (ja) 2017-08-24
MY164836A (en) 2018-01-30
KR20140089560A (ko) 2014-07-15
SG11201400933VA (en) 2014-04-28
EP3563680C0 (en) 2023-08-30
CA3074400A1 (en) 2013-05-02
JP6154391B2 (ja) 2017-06-28
EP3262932B1 (en) 2019-05-15
HK1200272A1 (en) 2015-08-07
PT3262932T (pt) 2019-08-26
PL3262932T3 (pl) 2019-10-31
SG10201603188SA (en) 2016-05-30
CY1121869T1 (el) 2020-10-14
LT2770821T (lt) 2017-12-11
EP4311833A2 (en) 2024-01-31
PT2770821T (pt) 2017-12-18
IL232097A (en) 2017-06-29
AU2016202688B2 (en) 2017-09-28
EP2770821A1 (en) 2014-09-03
AU2012324016C1 (en) 2018-02-15
CN104039132A (zh) 2014-09-10
EP3563680B1 (en) 2023-08-30
ES2651517T3 (es) 2018-01-26
US20200375160A1 (en) 2020-12-03
JP6574457B2 (ja) 2019-09-11
CN107254480A (zh) 2017-10-17
PL2770821T3 (pl) 2018-02-28
CA2850387A1 (en) 2013-05-02
KR20180128494A (ko) 2018-12-03
HUE045879T2 (hu) 2020-01-28
KR102074145B1 (ko) 2020-02-07
AU2012324016A8 (en) 2016-03-03
LT3262932T (lt) 2019-08-26
KR20200013810A (ko) 2020-02-07
JP2020146041A (ja) 2020-09-17
NZ623456A (en) 2016-05-27
CN107254480B (zh) 2021-08-10
JP6866409B2 (ja) 2021-04-28
IL252022A0 (en) 2017-06-29
MX2020010763A (es) 2022-04-01
CY1119657T1 (el) 2018-04-04
DK2770821T3 (da) 2017-11-27
RS56656B1 (sr) 2018-03-30
RS59082B1 (sr) 2019-09-30
MX2014004895A (es) 2014-09-12
CN104039132B (zh) 2017-06-16
HUE035652T2 (en) 2018-05-28
DK3262932T3 (da) 2019-08-05
EP4311833A3 (en) 2024-05-01
SI3262932T1 (sl) 2019-09-30
CN104039132B9 (zh) 2017-09-05
NZ719373A (en) 2018-06-29
US10869466B2 (en) 2020-12-22
KR101921126B1 (ko) 2018-11-23
JP2019068857A (ja) 2019-05-09
IL232097A0 (en) 2014-05-28

Similar Documents

Publication Publication Date Title
MX355725B (es) Ratones con complejo principal de histocompatibilidad modificado geneticamente.
MX355726B (es) Ratones transgenicos que expresan moleculas quimericas del complejo mayor de histocompatibilidad (cmh) clase ii.
CY1121223T1 (el) Ποντικοι οι οποιοι εκφραζουν ανθρωποποιημενο μειζον συμπλεγμα ιστοσυμβατοτητας
CY1121979T1 (el) Ποντικια που εκφραζουν ανθρωποποιημενους τ-λεμφοκυτταρικους συνυποδοχεις
EP4249507A3 (en) Transgenic mice expressing chimeric major histocompatibility complex (mhc) class ii molecules
PH12016500342A1 (en) Non-human animals having a humanized signal-regulatory protein gene
MX2017006802A (es) Animales no humanos que expresan el complejo cd3 humanizado.
MX2020007021A (es) Receptor quimerico de antigeno anti-cd19 humanizado.
MX2014015679A (es) Roedores con il-7 humanizada.
MX2022001201A (es) Ratones con genes insertados de sirp¿-il15 humanizadas y métodos para usarlos.
MX2017001008A (es) Tratamiento de cancer utilizando un receptor quimerico de antigeno cd33.
MX363013B (es) Animales genéticamente modificados y métodos para su obtención.
AU2013312359A8 (en) Genetically modified non-human animals and methods of use thereof
MX2012012689A (es) Anticuerpos que tienen inmunogenicidad reducida en un ser humano.
MY190711A (en) Treatment of cancer using humanized anti-egfrviii chimeric antigen receptor
MX370720B (es) Anticuerpos anti-gdf15.
MX2016008076A (es) Receptores quimericos de antigeno de mesotelina humana y uso de los mismos.
MX353134B (es) Ratones con receptor de linfocitos t modificados geneticamente.
MX2015013104A (es) Composiciones y métodos para la inmunoterapia.
SG10201908800YA (en) Non-human animals having humanized fc-gamma receptors
WO2014122035A3 (en) Induced dendritic cells and uses thereof
MX2021000586A (es) Ratones transgenicos que expresan moleculas quimericas del complejo mayor de histocompatibilidad (cmh) clase ii.
WO2012148538A3 (en) Anti-endoglin antibodies and knockin mice expressing novel human/mouse chimeric endoglin

Legal Events

Date Code Title Description
FG Grant or registration